Press Releases

Interest in cPAN and nutraceuticals grows

Interest continues to grow in the development of a new canine pancreatitis test and a ‘Prescribed’ brand of nutraceuticals, reports Avacta Animal Health.

Visitors at the London Vet Show went to the Avacta stand to find out more about the Canine Pancreatitis (cPAN) test and sign up a for a free trial of the company’s veterinary exclusive new Natural VetCare ‘Prescribed’ brand of nutraceuticals.

Hayley Booth, Avacta’s commercial manager, said:

“We had an awful lot of enquiries and interest in the cPAN test and we’ve had many people sign up for our free trial of the Natural VetCare range which we have become distributor for.
We also now have a page on the Avacta website where you can sign up for our free trial of Natural VetCare so we are hoping even more from the profession will take advantage of this great offer.”

Avacta’s innovative and rapid new cPAN test is the only test for acute canine pancreatitis that has been validated against two separate gold standard methods; histology and blinded clinical assessment.

Utilising the same approach as Avacta’s canine Lymphoma Blood Test (cLBT), cPAN works by using an algorithm to combine the serum levels of three biomarkers (amylase, lipase and alkaline phosphatise). Vets in practice will be given access to the algorithm via a website where they will obtain instant, easy to interpret results.

Since treatment for pancreatitis traditionally has required intensive intervention and hospitalisation, a rapid rule out test like cPAN represents a huge stride forward for the profession, said Avacta’s Hayley Booth.

“cPAN enables veterinary professionals to make rapid and reliable informed clinical decisions when confronted with the numerous common presentations encountered with pancreatitis.

It’s been optimised against clinical and histological confirmed cases of acute pancreatitis to provide optimal sensitivity and it also detects interstitial pancreatitis which is often missed by other methods. The test will be available in the first quarter of 2016.”

Many visitors to LVS signed up for a free full trial of Natural VetCare’s ‘Prescribed’ brand of nutraceuticals – premium veterinary exclusive supplements for cats and dogs.

Avacta has become distributor for the UK manufactured products which have been specially formulated for the British market and address some of the most common issues found in pets today such as skin problems, joint wear and tear and age related conditions.

Natural VetCare Prescribed will be available from March 2016, but Avacta Animal Health and Natural VetCare would like to invite vets to try some of the products on their own pets prior to launch, so that they can see the difference for themselves and, most importantly, so their pet can feel the difference.

If you would like to register to take part in Avacta’s free trial of these unique supplements please sign up at http://allergy.avactaanimalhealth.com/natural-vetcare-product-trial-form/

For more information email customer.services@avacta.com or call 0800 8494 550.

Avacta Animal Health unveils exciting new developments at London Vet Show (LVS)

Visitors to next week’s London Vet Show (LVS) at Olympia (November 19 and 20) will have plenty of reasons to visit Avacta Animal Health’s stand N30.

Veterinary professionals will be offered a free complete trial of an exclusive new Natural Vet Care ‘Prescribed’ brand of nutraceuticals, be able to learn more about Avacta’s new canine pancreatitis (cPAN) test and its innovative new CYNO-Dial and FELI-DIAL test, set to transform pet allergy treatment in the UK.

Avacta will also be encouraging veterinary teams to join a webinar on the canine Lymphoma Blood Test (cLBT) and are sponsors of a Thailand Adventure competition.

Visitors have the chance to win a once-in-a-lifetime trip to Thailand with Worldwide Veterinary Service (WVS), worth £12,000, simply by visiting the Avacta stand and other sponsors’ stands and getting their ‘passport’ stamped.

Attendees of the show can also sign up for a free trial of Avacta’s exclusive new Natural Vet Care ‘Prescribed’ brand of nutraceuticals.

The company has become distributor for this range of premium supplements for cats and dogs which are manufactured in the UK.

Products have been specially formulated for the British market to address some of the most common issues found in pets today – skin problems, joint wear and tear and age related conditions.

LVS visitors can also find out more about the development of Avacta’s new canine pancreatitis (cPAN) test.

Developed to provide a rapid test for acute canine pancreatitis, cPAN is the only test for canine pancreatitis that has been validated against two separate gold standard methods; histology and blinded clinical assessment.

A unique and innovative new test set to transform pet allergy treatment in the UK will also feature on the Avacta stand.

Working in partnership with Galileo Diagnostics (France), Avacta’s CYNO-DIAL (dog test) and FELI-DIAL (cat test) dramatically reduces the time needed to help vets prescribe the most appropriate diets for an elimination trial.

Requiring only a simple blood sample, both tests featuring at LVS have been billed as the next step after Avacta’s SENSITEST® food allergy test and detect the presence of specific IgE for each of the allergenic proteins contained in the various veterinary prescribed diets tested, alongside the animals’ existing diet.

Avacta Animal Health’s commercial manager, Hayley Booth, said:

“The Avacta team are very much looking forward to welcoming visitors to our stand. The team behind Natural VetCare have over thirty years’ experience in animal nutraceuticals and we’d invite you to try any of their products so that you can see the difference for yourself, and most importantly your pet can feel the difference.”

“It’s an exciting time for us and we can’t wait to share news on all our fabulous new products as well as invite people to join Iain Grant for his webinar on cLBT.”

At the show Avacta will be highlighting a forthcoming prognosis webinar on the canine Lymphoma Blood Test (cLBT) with Iain Grant DipACVIM, the University of Glasgow, which takes place on Tuesday, December 1 at 7pm.

Iain will share insights and experience from first opinion practice on the test. Increasing use of cLBT is beginning to highlight new areas where the test can be helpful to both practitioners and clients.

During the webinar data and case studies will show how cLBT assists first opinion practitioners in their treatment and monitoring of lymphoma in dogs and can help keep clients well informed about the treatment and prognosis of lymphoma in their pet.

To sign-up for the webinar on December 1 follow the link:
http://www.veterinarywebinars.com/avacta-clbt/

Visitors to the London Vet Show on November 19 and 20 can visit Avacta Animal Health at stand N30.

For more information visit www.avactaanimalhealth.com, email customer.services@avacta.com or call 0800 8494 550.

New publication focuses on SENSITEST® canine Lymphoma Blood Test

Avacta Animal Health’s SENSITEST® canine Lymphoma Blood Test (cLBT) is the subject of an early view, open access paper published online by Veterinary and Comparative Oncology on the 15th of October. The paper, ‘Utility of a multiple serum biomarker test to monitor remission status and relapse in dogs with lymphoma undergoing treatment with chemotherapy’, discusses the results of a blinded retrospective study using the simple, relatively non-invasive cLBT to investigate remission and recurrence of lymphoma in dogs undergoing chemotherapy.
(more…)

Avacta Animal Health’s SENSITEST® canine Lymphoma Blood Test featured at VCS 2014

Delegates at this year’s Veterinary Cancer Society (VCS) Annual Conference in St Louis, USA, heard how Avacta Animal Health’s SENSITEST® canine Lymphoma Blood Test (cLBT) could aid remission monitoring. Assessment of the clinical utility of a multivariate serum biochemical test for remission monitoring in canine lymphoma, presented by Dr Sue Ettinger, DVM, Diplomate ACVIM (Oncology), staff medical oncologist at the Animal Specialty Center in Yonkers, New York, focused on how this simple, biomarker-based test offers greater sensitivity than traditional palpation and cytological techniques, enabling earlier detection of recurrence.

Dr Ettinger explained: “Lymphoma is a cancer that progresses very rapidly; a patient seemingly in remission can appear to relapse just a couple of days later when, in reality, the disease has actually been progressing unnoticed. We monitored ‘healthy’ patients thought to be in remission using the cLBT, and the results were impressive. Patients with elevated results – indicating a possible relapse – were recalled after two weeks rather than the usual four to six weeks, and were found to have enlarged lymph nodes; they had indeed come out of remission. Clinically, the cLBT is proving a very valuable and economical test. It is minimally invasive with no sedation required, achieves good results at a cost that is comparable to performing a lymph node aspirate, and the results are more consistent.”

For more information, visit www.avactaanimalhealth.com

Join Our Free CPD Event

Understanding new insights in veterinary oncology with Avacta Animal Health

Avacta Animal Health invites members of the veterinary profession to join a free CPD seminar on the latest advances in veterinary oncology at the Thorp Park Hotel, Leeds, at 7pm on the 28th of October. Entitled Understanding new insights into veterinary oncology to help advance your practice, this free lecture will be delivered by renowned veterinary oncologists Dr Carolyn J Henry and Dr Jeff Bryan, and will provide an informative and interactive look at recent developments in the field, as well as practical recommendations that you can apply to the care of your companion animal patients.

Henry1Dr Carolyn J Henry is professor of oncology with dual appointments at the College of Veterinary Medicine and the School of Medicine at the University of Missouri. She is past president of both the Veterinary Cancer Society and the American College of Veterinary Internal Medicine Specialty of Oncology, and is a member of the European Society of Veterinary Oncology.

jeff bryanDr Jeff Bryan is associate professor of oncology, director of the Comparative Oncology Laboratory and section chief for oncology at the College of Veterinary Medicine at the University of Missouri. He is the current president of the American College of Veterinary Internal Medicine Specialty of Oncology, and his research focuses on the epigenetics of cancer.

In order to secure your place, please provide us with your name, position, practice and contact details to marketing@avacta.com by Tuesday 14th October.

Man’s best friend gets a new lease of life

Nearly one out of four dogs will develop cancer in their lifetime and 20 per cent of those will be lymphoma cases.
A team of researchers at the University of Leicester, led by Professor Alexander Gorban from the Department of Mathemathics, has helped Avacta Animal Health Ltd to develop a new user-friendly electronic system for diagnosing lymphoma in dogs in the early stages, and for remission monitoring.

To view the full article click here